@article {Bhuiyan2021.09.27.21264168, author = {Alauddin Bhuiyan and Pallab Kanti Roy and Tasin Bhuiyan and Elsdon Storey and Walter P Abhayaratna and Mandip Dhamoon and R. Theodore Smith and Kotagiri Ramamohanarao}, title = {A Novel Retinal Vascular Feature and Machine Learning-based Brain White Matter Lesion Prediction Model}, elocation-id = {2021.09.27.21264168}, year = {2021}, doi = {10.1101/2021.09.27.21264168}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {White matter lesion (WML) is one of the common cerebral abnormalities, it indicates changes in the white matter of human brain and have shown significant association with stroke, dementia and deaths. Magnetic resonance imaging (MRI) of the brain is frequently used to diagnose white matter lesion (WML) volume. Regular screening can detect WML in early stage and save from severe consequences. Current option of MRI based diagnosis is impractical for regular screening because of its high expense and unavailability. Thus, earlier screening and prediction of the WML volume/load specially in the rural and remote areas becomes extremely difficult. Research has shown that changes in the retinal micro vascular system reflect changes in the cerebral micro vascular system. Using this information, we have proposed a retinal image based WML volume and severity prediction model which is very convenient and easy to operate.Our proposed model can help the physicians to detect the patients who need immediate and further MRI based detail diagnosis of WML. Our model uses quantified measurement of retinal micro-vascular signs (such as arteriovenular nicking (AVN), Opacity (OP) and focal arteriolar narrowing (FAN)) as input and estimate the WML volume/load and classify its severity. We evaluate our proposed model on a dataset of 111 patients taken from the ENVISion study which have retinal and MRI images for each patient. Our model shows high accuracy in estimating the WML volume, mean square error (MSE) between our predicted WML load and manually annotated WML load is 0.15. The proposed model achieves an F1 score of 0.92 in classifying the patients having mild and severe WML load.The preliminary results of our study indicate that quantified measurement of retinal micro-vascular features (AVN, OP and FAN) can more accurately identify the patients who have high risk of cardio-vascular diseases and dementia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBrain MRI and retinal vascular imaging data used in this work are obtained from the ENVISion [14] study. All participants have given written consent separately for the ENVIS-ion trial. Protocols of ENVIS-ion study have been approved by the Monash University health and research ethics committee. Our study is approved as a low-risk project under the ENVIS-ion study by the Alfred hospital ethics committee, Melbourne, Victoria. Therefore, we have access to only imaging data of this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Brain MRI and retinal vascular imaging data used in this work are obtained from the ENVISion [14] study. All participants have given written consent separately for the ENVIS-ion trial. Protocols of ENVIS-ion study have been approved by the Monash University health and research ethics committee. Our study is approved as a low-risk project under the ENVIS-ion study by the Alfred hospital ethics committee, Melbourne, Victoria. Therefore, we have access to only imaging data of this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A}, URL = {https://www.medrxiv.org/content/early/2021/09/29/2021.09.27.21264168}, eprint = {https://www.medrxiv.org/content/early/2021/09/29/2021.09.27.21264168.full.pdf}, journal = {medRxiv} }